Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Arctera State of AI Governance 2026 Finds More Than Three-Quarters (78%) of Organizations Using AI Expect Communications Risk to Rise, But Fewer Than One in Five Can Prove AI Governance Readiness
-
Westlake Announces Second Quarter 2026 Conference Call
-
Westlake Chemical Partners Announce Second Quarter 2026 Conference Call
-
Abundia Global Impact Group Expands Leadership Team with the Appointment of Keith Berger as Chief Commercial Officer
-
GAfix.ai Expands Its Google Analytics Audit to Include Google Tag Manager
-
OSS Receives Production Order from Commercial Robotics Customer
-
PatientsLikeMe and Science 37 Partner to Unlock Trial Access for Interested, Eligible Patients
-
Exyn Defense Advances U.S. Government Strategy with Green UAS Certification Initiative for Nexys Autonomous Mapping Platform
-
Arteris to Announce Financial Results for the Second Quarter 2026 on Thursday, August 6, 2026
-
Business Insider Launches Standalone FAST Channel, Partners with Magnite’s SpringServe for Next Phase of Streaming Growth
-
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
-
Oxford Lane Capital Corp. Schedules First Fiscal Quarter Earnings Release and Conference Call for July 28, 2026
-
Monaco Associates’ Book Launch Practice Acquired by Caraballo & Co.
-
Altia Launches Altia AI, an Intelligent Layer That Helps HMI Teams Build, Debug and Optimize Faster Without Compromising Production Code
-
Q2 report Fenix Outdoor International AG
-
Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care
-
Lonza and Engitix Announce License Agreement to Advance Targeted ADC Development
-
Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule
-
FDH Aero and LATECOERE Announce Global Hardware Supply Agreement
-
Crypto News: MemeToro Launches AI Agent Rankings as Platform Development Continues
-
XA Investments President Kimberly Flynn Dispels Misinformation Ahead of XFLT Proxy Vote
-
ZenaTech's ZenaDrone Subsidiary Begins Scheduling U.S. Government Defense Demonstrations, Starting with First Confirmed Agency Engagement
-
ZenaTech's ZenaDrone Subsidiary Begins Scheduling U.S. Government Defense Demonstrations, Starting with First Confirmed Agency Engagement
-
Correction: Agentic Day Lands in Toronto, Completing a Three-Country, Two-Continent 2026 Series
-
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GPGI, Inc.
-
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Blue Owl Technology Finance Corp.
-
Shareholder Alert: Ademi LLP investigates whether NextCure, Inc. is obtaining a Fair Price for Public Shareholders
-
Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders
-
Over 20 International Mainstream Media Outlets Explore Innovation and Vitality in Harbin
-
Shareholder Alert: Ademi LLP investigates whether TriCo Bancshares is obtaining a Fair Price for Public Shareholders
-
Shareholder Alert: Ademi LLP investigates whether Element Solutions is obtaining a Fair Price for Public Shareholders
-
Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly
-
ParaZero Receives Follow-On Order for Operational System Protecting High-Value Assets and Critical Infrastructure
-
Brixton Metals Drills 5,015 g/t Silver over 20m in a New Brownfields Discovery Area at Its Langis Project
-
FreightCar America, Inc. Continues Aftermarket Expansion with Acquisition of Leading Regional Distributor
-
Arq Schedules Second Quarter 2026 Earnings Conference Call
-
NIOB Seigneurie Assays Confirm Niobium Mineralization in hole seven
-
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
-
Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
-
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
-
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
-
Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance Investors
-
Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®
-
Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles
-
EU Proposes to Embed CORSIA into Law Through 2035 as Base Carbon’s Rwanda Inventory Becomes Fully CORSIA-Eligible
-
Woodward Inaugurates Expanded Production for High-Speed Fuel Injection Systems in Glatten, Germany
-
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
-
Dragonfly Energy Appoints Transportation Industry Veteran Robert Keller to Lead National Fleet Sales
-
PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada
-
United Community Banks, Inc. Reports Second Quarter Earnings
